In this study36, the animals received intraperitoneal injections of 2.5 mg per kg body weight of ACE2-Fd (a fusion protein consisting of the human ACE2 ectodomain and the T4 fibritin trimerization foldon) on days 1–5 after intranasal infection with SARS-CoV-2. Here, ACE2 is linked to infection.